Author
Listed:
- Claire Bernardeau
(Grenoble Alpes University Hospital, University Grenoble Alpes)
- Bruno Revol
(Grenoble Alpes University Hospital, University Grenoble Alpes
University Grenoble Alpes, Inserm U1300, HP2)
- Francesco Salvo
(Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219
CHU de Bordeaux)
- Michele Fusaroli
(University of Bologna)
- Emanuel Raschi
(University of Bologna)
- Jean-Luc Cracowski
(Grenoble Alpes University Hospital, University Grenoble Alpes
University Grenoble Alpes, Inserm U1300, HP2)
- Matthieu Roustit
(University Grenoble Alpes, Inserm U1300, HP2
University Grenoble Alpes)
- Charles Khouri
(Grenoble Alpes University Hospital, University Grenoble Alpes
University Grenoble Alpes, Inserm U1300, HP2
University Grenoble Alpes)
Abstract
Background Previous meta-epidemiological surveys have found considerable misinterpretation of results of disproportionality analyses. We aim to explore the relationship between the strength of causal statements used in title and abstract conclusions of pharmacovigilance disproportionality analyses and the strength of causal language used in citing studies. Methods On March 30, 2022, we selected the 30 disproportionality studies with the highest Altmetric Attention Scores. For each article, we extracted all citing studies using the Dimension database (n = 1434). In parallel, two authors assessed the strength of causal statements in the title and abstract conclusions of source articles and in the paragraph of citing studies. Based on previous studies, the strength of causal language was quantified based on a four-level scale (1—appropriate interpretation; 2—ambiguous interpretation; 3—conditionally causal; 4—unconditionally causal). Discrepancies were solved by discussion until consensus among the team. We assessed the association between the strength of causal statements in source articles and citing studies, separately for the title and abstract conclusions, through multinomial regression models. Results Overall, 27% (n = 8) of source studies used unconditionally causal statements in their title, 30% (n = 9) in their abstract conclusion, and 17% (n = 5) in both. Only 20% (n = 6) used appropriate statements in their title and in their abstract’s conclusions. Among the 622 citing studies analyzed, 285 (45.8%) used unconditionally causal statements when referring to the findings from disproportionality analysis, and only 164 (26.4%) used appropriate language. Multinomial models found that the strength of causal statements in citing studies was positively associated with the strength of causal language used in abstract conclusions of source articles (Likelihood Ratio Test (LogLRT) p
Suggested Citation
Claire Bernardeau & Bruno Revol & Francesco Salvo & Michele Fusaroli & Emanuel Raschi & Jean-Luc Cracowski & Matthieu Roustit & Charles Khouri, 2025.
"Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study,"
Drug Safety, Springer, vol. 48(6), pages 679-688, June.
Handle:
RePEc:spr:drugsa:v:48:y:2025:i:6:d:10.1007_s40264-025-01524-x
DOI: 10.1007/s40264-025-01524-x
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:48:y:2025:i:6:d:10.1007_s40264-025-01524-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.